Found: 24
Select item for more details and to access through your institution.
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
- By:
- Publication type:
- Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour DNA Mutations.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 8, p. 769, doi. 10.3390/cells8080769
- By:
- Publication type:
- Article
Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0207876
- By:
- Publication type:
- Article
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2997, doi. 10.1111/liv.15014
- By:
- Publication type:
- Article
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231171574
- By:
- Publication type:
- Article
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 9379, doi. 10.2147/CMAR.S330195
- By:
- Publication type:
- Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71577-8
- By:
- Publication type:
- Article
Is there any place for novel agents in treating biliary tract cancer?
- Published in:
- Medical Oncology, 2021, v. 38, n. 2, p. 1, doi. 10.1007/s12032-021-01463-4
- By:
- Publication type:
- Article
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22543-z
- By:
- Publication type:
- Article
Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1178, doi. 10.3390/cancers13051178
- By:
- Publication type:
- Article
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 213, doi. 10.3390/cancers13020213
- By:
- Publication type:
- Article
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.
- Published in:
- CardioVascular & Interventional Radiology, 2023, v. 46, n. 1, p. 49, doi. 10.1007/s00270-022-03288-8
- By:
- Publication type:
- Article
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2828, doi. 10.3390/jcm10132828
- By:
- Publication type:
- Article
Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1310, doi. 10.1002/ijc.34182
- By:
- Publication type:
- Article
Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 128, doi. 10.3390/ph14020128
- By:
- Publication type:
- Article
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 1, p. 139, doi. 10.1007/s11523-022-00933-7
- By:
- Publication type:
- Article
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 653, doi. 10.1007/s11523-021-00834-1
- By:
- Publication type:
- Article
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article